http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE33963-E

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 1991-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-RE33963-E
titleOfInvention Solid rapidly released medicament preparations containing dihydropyridines, and processes for their preparation
abstract Solid dihydropyridines, e.g. nifedipine and nimodipine preparations having a maximum standard deviation of the active compound content of 3% contain 1 part by weight of nifedipine, 2 to 6 parts by weight of PVP with a mean molecular weight of 15,000 to 50,000, 3.5 to 15 parts by weight of cellulose, 0.25 to 4 parts by weight of starch and 0.5 to 4 parts by weight of cross-linked insoluble PVPP, and, if appropriate, one or more further pharmaceutical auxiliaries and excipients. These preparations show a good release of dihydropyridine with good content uniformity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006257470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5543099-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5266581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5478848-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423700-A1
priorityDate 1981-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4216155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4412986-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54167661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56988648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135752889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129113828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14550603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67914500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235095497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4497

Total number of triples: 44.